Evidence map›Paper›PMID 21102463›Full record

SynthesisNature genetics2010

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Andre Franke, Dermot P B McGovern, Jeffrey C Barrett, Kai Wang, Graham L Radford-Smith, Tariq Ahmad, Charlie W Lees, Tobias Balschun, James Lee, Rebecca Roberts and 86 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,404 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,404citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,404 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,344 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

96 authors.

Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany.
Dermot P B McGovern
Jeffrey C Barrett
Kai Wang
Graham L Radford-Smith
Tariq Ahmad
Charlie W Lees
Tobias Balschun
James Lee
Rebecca Roberts
Carl A Anderson
Joshua C Bis
Suzanne Bumpstead
David Ellinghaus
Eleonora M Festen
Michel Georges
Todd Green
Talin Haritunians
Luke Jostins
Anna Latiano
Christopher G Mathew
Grant W Montgomery
Natalie J Prescott
Soumya Raychaudhuri
Jerome I Rotter
Philip Schumm
Yashoda Sharma
Lisa A Simms
Kent D Taylor
David Whiteman
Cisca Wijmenga
Robert N Baldassano
Murray Barclay
Theodore M Bayless
Stephan Brand
Carsten Büning
Albert Cohen
Jean-Frederick Colombel
Mario Cottone
Laura Stronati
Ted Denson
Martine De Vos
Renata D'Inca
Marla Dubinsky
Cathryn Edwards
Tim Florin
Denis Franchimont
Richard Gearry
Jürgen Glas
Andre Van Gossum
Stephen L Guthery
Jonas Halfvarson
Hein W Verspaget
Jean-Pierre Hugot
Amir Karban
Debby Laukens
Ian Lawrance
Marc Lemann
Arie Levine
Cecile Libioulle
Edouard Louis
Craig Mowat
William Newman
Julián Panés
Anne Phillips
Deborah D Proctor
Miguel Regueiro
Richard Russell
Paul Rutgeerts
Jeremy Sanderson
Miquel Sans
Frank Seibold
A Hillary Steinhart
Pieter C F Stokkers
Leif Torkvist
Gerd Kullak-Ublick
David Wilson
Thomas Walters
Stephan R Targan
Steven R Brant
John D Rioux
Mauro D'Amato
Rinse K Weersma
Subra Kugathasan
Anne M Griffiths
John C Mansfield
Severine Vermeire
Richard H Duerr
Mark S Silverberg
Jack Satsangi
Stefan Schreiber
Judy H Cho
Vito Annese
Hakon Hakonarson
Mark J Daly
Miles Parkes

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
Inflammatory Bowel Disease Genetics Consortium Data Coordinating CenterU01DK062429 · NIDDK · YALE UNIVERSITY · PI CHO, JUDY H. · 2002 to 2016
$16.8M
Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBDU24DK062429 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ling-shiang Chuang, Ron Do · 2017 to 2026
$13.9M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
IBD Gene Mapping by Clinical and Population SubsetsU01DK062431 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Steven R Brant · 2002 to 2026
$10.7M
Universite de Montreal IBD Genetics Research CenterU01DK062432 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI John D. Rioux · 2002 to 2026
$9.6M
NIDDK IBD Genetics Consortium Genetic Research CenterU01DK062420 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2002 to 2021
$7.8M
Identification of the IBD genes on chromosomes 3p and 6pR01DK064869 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI RIOUX, JOHN D. · 2003 to 2016
$7.8M
Chief Scientist Office CZB/4/540Medical Research Council G0600329Medical Research Council G0800675Medical Research Council G0800759NCRR NIH HHS M01 RR000425NCRR NIH HHS M01-RR00425NHLBI NIH HHS N01 HC015103NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC075150NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01 HC-55222NHLBI NIH HHS N01-HC-75150NHLBI NIH HHS N01-HC-85079NHLBI NIH HHS N01-HC-85080NHLBI NIH HHS N01-HC-85081NHLBI NIH HHS N01-HC-85082NHLBI NIH HHS N01-HC-85083NHLBI NIH HHS N01-HC-85084NHLBI NIH HHS N01-HC-85085NHLBI NIH HHS N01-HC-85086NHLBI NIH HHS R01 HL087652NHLBI NIH HHS U01 HL080295NIAMS NIH HHS K08 AR055688NIDDK NIH HHS DK062413NIDDK NIH HHS DK062420NIDDK NIH HHS DK062422NIDDK NIH HHS DK062423NIDDK NIH HHS DK062429NIDDK NIH HHS DK062431NIDDK NIH HHS DK062432NIDDK NIH HHS DK 063491NIDDK NIH HHS DK064869NIDDK NIH HHS DK069513NIDDK NIH HHS DK084554NIDDK NIH HHS DK76984NIDDK NIH HHS K23 DK069513NIDDK NIH HHS P01 DK046763NIDDK NIH HHS P01-DK046763NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK064869NIDDK NIH HHS R03 DK076984NIDDK NIH HHS R21 DK084554NIDDK NIH HHS U01 DK062413NIDDK NIH HHS U01 DK062420NIDDK NIH HHS U01 DK062422NIDDK NIH HHS U01 DK062423NIDDK NIH HHS U01 DK062429NIDDK NIH HHS U01 DK062431NIDDK NIH HHS U01 DK062432NIDDK NIH HHS U24 DK062429Wellcome Trust 089120Wellcome Trust WT089120/Z/09/Z
6 · The paper itself

Abstract

We undertook a meta-analysis of six Crohn's disease genome-wide association studies (GWAS) comprising 6,333 affected individuals (cases) and 15,056 controls and followed up the top association signals in 15,694 cases, 14,026 controls and 414 parent-offspring trios. We identified 30 new susceptibility loci meeting genome-wide significance (P < 5 × 10⁻⁸). A series of in silico analyses highlighted particular genes within these loci and, together with manual curation, implicated functionally interesting candidate genes including SMAD3, ERAP2, IL10, IL2RA, TYK2, FUT2, DNMT3A, DENND1B, BACH2 and TAGAP. Combined with previously confirmed loci, these results identify 71 distinct loci with genome-wide significant evidence for association with Crohn's disease.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyComputational BiologyCrohn DiseaseGenetic LinkageGenetic LociGenetic VariationGenome, HumanHumansReproducibility of Results

Identifiers

PMID21102463
PMCPMC3299551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.